India's GlaxoSmithKline Pharma hits record high

GlaxoSmithKline Pharmaceuticals

10/01/2024 06:15

** Shares of GlaxoSmithKline Pharmaceuticals  GLAX.NS  rise
as much as 8.3% to a record 2,259 rupees; last up 4.9%
    ** Reuters could not immediately verify the reason for the
move
    ** Stock last hit all-time highs in December while logging
gains for 11 straight sessions 
    ** Stock has risen about 5% twice so far in January and had
risen about 5% thrice throughout 2023
    ** Avg analyst rating on GLAX stock is "hold", same as rival
Dr Reddy's  REDY.NS ; Sun Pharma  SUN.NS , Cipla's  CIPL.NS  avg
rating is "buy" - LSEG data
    ** GLAX's avg PT is 1,686.5 rupees, 23% lower than current
price - LSEG data

 (Reporting by Varun Vyas in Bengaluru)
 ((varunvyas.hebbalalu@thomsonreuters.com))